MarketCap
China SXT Pharmaceuticals SXTC
€ 0.04
-5.75%
Facebook
X
Telegram
Land |
 China |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
680 K |
Marktkapitalisierung |
$ 27.2 K |
EBITDA (LTM) |
$ -7.05 M |
P/E (LTM) |
-0.007667 |
P/S (LTM) |
0.041804 |
EPS (LTM) |
-9.13 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
BeyondSpring
BYSI
|
$ 0.43 | -3.15 % | $ 17.7 M | Nasdaq Capital Market |  USA |
 |
Pliant Therapeutics
PLRX
|
$ 0.86 | -0.2 % | $ 52.8 M | Nasdaq Global Select Market | USA |
 |
Forward Pharma A/S
FWP
|
- | -0.75 % | $ 18.7 M | Nasdaq Capital Market |  Danmark |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.27 | -2.68 % | $ 66.7 M | Nasdaq Global Select Market | USA |
 |
Cabaletta Bio
CABA
|
$ 1.47 | -3.29 % | $ 148 M | Nasdaq Global Select Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
Regulus Therapeutics
RGLS
|
- | - | $ 155 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.29 | -3.01 % | $ 136 M | Nasdaq Global Market |  Niderland |
 |
Prothena Corporation plc
PRTA
|
$ 8.2 | -0.61 % | $ 441 M | Nasdaq Global Select Market,SPB | USA |
 |
Marinus Pharmaceuticals
MRNS
|
- | - | $ 29.6 M | Nasdaq Global Select Market | USA |
 |
PTC Therapeutics
PTCT
|
$ 60.59 | -3.89 % | $ 4.82 B | Nasdaq Global Select Market,SPB | USA |
 |
NeuBase Therapeutics
NBSE
|
- | -1.56 % | $ 12.3 M | Nasdaq Global Select Market | USA |
 |
Catalyst Biosciences
CBIO
|
$ 12.82 | -2.44 % | $ 1.15 B | Nasdaq Capital Market | USA |
 |
Arcus Biosciences
RCUS
|
$ 18.54 | -4.24 % | $ 1.99 B | NYSE,SPB | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Scopus BioPharma
SCPS
|
- | -48.37 % | $ 3.71 M | Nasdaq Global Select Market | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 13.21 | -0.11 % | $ 11 B | NYSE |  India |
 |
Regeneron Pharmaceuticals
REGN
|
$ 805.02 | -1.72 % | $ 84.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Codexis
CDXS
|
$ 1.28 | -2.29 % | $ 112 M | Nasdaq Global Select Market | USA |
 |
scPharmaceuticals
SCPH
|
- | - | $ 218 M | Nasdaq Global Select Market | USA |
 |
Rafael Holdings
RFL
|
$ 1.31 | 3.97 % | $ 38.5 M | NYSE | USA |
 |
Rigel Pharmaceuticals
RIGL
|
$ 48.13 | -1.49 % | $ 866 M | Nasdaq Global Select Market | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Cullinan Management
CGEM
|
$ 14.37 | -3.69 % | $ 866 M | Nasdaq Global Select Market | USA |
 |
Compugen Ltd.
CGEN
|
$ 1.94 | -1.02 % | $ 181 M | Nasdaq Global Market,SPB |  Israel |
 |
Royalty Pharma plc
RPRX
|
$ 63.86 | 0.17 % | $ 27.4 B | Nasdaq Global Select Market | USA |
 |
Inozyme Pharma
INZY
|
- | - | $ 207 M | Nasdaq Global Select Market | USA |
 |
Sigilon Therapeutics
SGTX
|
- | - | $ 728 M | Nasdaq Global Select Market | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Rubius Therapeutics
RUBY
|
- | -33.55 % | $ 7.81 M | Nasdaq Global Select Market | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
SIGA Technologies
SIGA
|
$ 3.12 | -0.95 % | $ 223 M | Nasdaq Global Select Market | USA |
 |
TRACON Pharmaceuticals
TCON
|
- | -1.38 % | $ 46.8 M | Nasdaq Capital Market | USA |
 |
Revance Therapeutics
RVNC
|
- | - | $ 309 M | Nasdaq Global Select Market | USA |
 |
Sierra Oncology
SRRA
|
- | -0.05 % | $ 1.34 B | Nasdaq Global Select Market |  Canada |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.04 | -0.25 % | $ 329 M | Nasdaq Global Select Market | USA |
 |
Soligenix
SNGX
|
$ 0.37 | 0.14 % | $ 1.92 M | Nasdaq Capital Market | USA |
 |
Sanofi
SNY
|
$ 41.6 | -0.86 % | $ 50.8 B | Nasdaq Global Select Market |  France |
 |
Collegium Pharmaceutical
COLL
|
$ 22.96 | -2.3 % | $ 727 M | Nasdaq Global Select Market | USA |
 |
Vaccinex
VCNX
|
- | -61.37 % | $ 654 K | Nasdaq Global Select Market | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
- | -19.68 % | $ 18.4 M | Nasdaq Capital Market | Canada |
 |
Spruce Biosciences
SPRB
|
$ 45.15 | -1.85 % | $ 34.6 M | Nasdaq Global Select Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.11 | -1.77 % | $ 62.2 M | Nasdaq Global Select Market | USA |
 |
Curis
CRIS
|
$ 0.39 | -4.59 % | $ 5.13 M | Nasdaq Global Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Corvus Pharmaceuticals
CRVS
|
$ 10.53 | -1.13 % | $ 831 M | Nasdaq Global Market | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 17.73 | -2.48 % | $ 1.78 B | Nasdaq Global Select Market,SPB | USA |
 |
CytomX Therapeutics
CTMX
|
$ 2.32 | -4.92 % | $ 320 M | Nasdaq Global Select Market | USA |